Press Releases

5-Hydroxytryptamine Receptor Market Expected to Achieve US $ 16.5 Bn by 2031 | CAGR 7.8%

Global 5-Hydroxytryptamine Receptor Market is expected to reach US$ 16.5 Bn in 2031 with a growth rate of 7.8%. The 5-Hydroxytryptamine (5-HT) Recepto

  • Date: 18 Jun, 2024
  • Author: Sagar Karlekar
Agrobacterium tumefaciens Competent Cells Market is Forecasted to Hit US$ 310 Mn By 2031 | CAGR 11.5%

The Agrobacterium tumefaciens Competent Cells Market is a niche segment within the broader biotechnology industry, catering to the needs of plant gene

  • Date: 18 Jun, 2024
  • Author: Sagar Karlekar
Adulticides Market is Forecasted to Hit US$ 14.4 Bn By 2031 | CAGR 8.4%

The Global Adulticides Market is projected to reach US$ 14.4 Bn by 2031, exhibiting a robust compound annual growth rate (CAGR) of 8.4% during the for

  • Date: 17 Jun, 2024
  • Author: Sagar Karlekar
Hot Flashes Market is Forecasted to Hit US$ 3.8 Bn By 2031 | CAGR 8.7%

The global hot flashes market, a segment of the healthcare industry focused on developing and providing treatment options for managing hot flashes exp

  • Date: 17 Jun, 2024
  • Author: Sagar Karlekar
Allergy Rhinitis Drug Market is Forecasted to Hit US$ 25.7 Bn By 2031 | CAGR 6.8%

The Allergy Rhinitis Drug Market, a crucial segment of the pharmaceutical industry, is poised for substantial growth in the coming years. This market

  • Date: 13 Jun, 2024
  • Author: Sagar Karlekar
Glucagon-Like Peptide 1 (GLP-1) Drugs Market Expected to Achieve US$ 18.2 Bn by 2031 | CAGR 12.1%

The Glucagon-Like Peptide 1 (GLP-1) Drugs Market falls under the pharmaceutical industry and focuses on the development, production, and commercializa

  • Date: 11 Jun, 2024
  • Author: Sagar Karlekar
Ambroxol Market is Forecasted to Hit US$ 720.1 Mn By 2031 | CAGR 5.2%

The Global Ambroxol Market is expected to reach US$ 720.1 Million in 2031 with a growth rate of 5.2%. Ambroxol is a mucolytic agent used to treat resp

  • Date: 10 Jun, 2024
  • Author: Sagar Karlekar
Aminoglycoside Antibiotics Market Expected to Achieve US$ 2.2 Bn by 2030 | CAGR 7.8%

The Global Aminoglycoside Antibiotics Market is expected to reach US$ 2.2 Bn by 2031, growing at a CAGR of 7.8% from 2024 to 2031.

  • Date: 10 Jun, 2024
  • Author: Sagar Karlekar
Aminophylline Market is Forecasted to Hit US$ 1.9 Bn By 2031 | CAGR 6.2%

The Global Aminophylline Market, a segment of the pharmaceutical industry, is projected to reach US$ 1.9 Bn by 2031, growing at a Compound Annual Grow

  • Date: 10 Jun, 2024
  • Author: Sagar Karlekar
Menopause Market is Forecasted to Hit US$ 24.0 Bn By 2031 | CAGR 6.8%

The Global Menopause Market is poised for significant growth, projected to reach a valuation of US$ 24.0 Bn by 2031, driven by a robust compound annua

  • Date: 08 Jun, 2024
  • Author: Sagar Karlekar
Heavy Menstrual Bleeding (HMB) Market is Forecasted to Hit US$ 2.4 Bn By 2031 | CAGR 8.9%

The Global Heavy Menstrual Bleeding (HMB) Market, which falls under the medical devices and pharmaceuticals industries, is expected to reach US$ 2.4 B

  • Date: 16 May, 2024
  • Author: Sagar Karlekar
Fibrocystic Breast Condition Market is Forecasted to Hit US$ 2.2 Bn By 2031 | CAGR 7.8%

The Global Fibrocystic Breast Condition Market, which encompasses the pharmaceutical and medical device industries, is expected to reach US$ 2.2 Bn by

  • Date: 14 May, 2024
  • Author: Sagar Karlekar
Premature Ejaculation Market is Forecasted to Hit US$ 5.8 Bn By 2031 | CAGR 9.2%

Premature Ejaculation Market Expected to Achieve US$ 5.8 Bn by 2031, with registering a CAGR of 9.2% during the forecast year. The global Premature Ej

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Fallopian Tube Cancer Market is Forecasted to Hit US$ 1,052.1 Mn By 2031 | CAGR 11.2%

Fallopian Tube Cancer Market Expected to Achieve US$ 1,052.1 Million by 2031, registering a CAGR 11.2% during the forecast year. The Fallopi

  • Date: 12 May, 2024
  • Author: Sagar Karlekar
Epithelial Ovarian Cancer Market is Forecasted to Hit US$ 3.9 Bn By 2031 | CAGR 10.2%

The Epithelial Ovarian Cancer Market is Expected to Achieve US$ 3.9 Bn by 2031, registering a CAGR of 10.2% during the forecast period. The Globa

  • Date: 12 May, 2024
  • Author: Sagar Karlekar